FMR LLC boosted its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 134.0% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,516,448 shares of the company's stock after purchasing an additional 4,304,896 shares during the quarter. FMR LLC owned about 4.42% of Option Care Health worth $235,265,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. UMB Bank n.a. raised its stake in shares of Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company's stock worth $26,000 after buying an additional 750 shares in the last quarter. GAMMA Investing LLC raised its position in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock worth $28,000 after acquiring an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. lifted its holdings in Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock valued at $47,000 after acquiring an additional 1,446 shares during the last quarter. Blue Trust Inc. boosted its position in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after purchasing an additional 377 shares in the last quarter. Finally, International Assets Investment Management LLC grew its stake in shares of Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock worth $91,000 after purchasing an additional 2,757 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.
Option Care Health Trading Up 1.1 %
Option Care Health stock traded up $0.25 during trading hours on Monday, reaching $24.05. 1,261,608 shares of the company's stock traded hands, compared to its average volume of 1,548,436. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63. The firm's 50 day moving average is $26.84 and its 200-day moving average is $28.87. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market capitalization of $4.09 billion, a price-to-earnings ratio of 20.00, a PEG ratio of 2.46 and a beta of 1.32.
Wall Street Analyst Weigh In
OPCH has been the subject of several research reports. Bank of America lowered Option Care Health from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. JMP Securities raised their target price on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th. Jefferies Financial Group downgraded Option Care Health from a "buy" rating to a "hold" rating and decreased their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, Barrington Research cut their price objective on Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $30.83.
Get Our Latest Analysis on Option Care Health
Insider Buying and Selling
In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company's stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now owns 326,334 shares of the company's stock, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is owned by insiders.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
